Quick Answer
Krystal Biotech, Inc. reported Net Income of $204.83 million for fiscal year 2025.
Krystal Biotech, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $204.83M | +129.7% |
| 2024 | $89.16M | +715.6% |
| 2023 | $10.93M | +107.8% |
| 2022 | -$139.97M | -101.2% |
| 2021 | -$69.57M | -116.3% |
| 2020 | -$32.17M | -68.5% |
| 2019 | -$19.09M | -75.3% |
| 2018 | -$10.89M | -37.5% |
| 2017 | -$7.92M | -588.7% |
| 2016 | -$1.15M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $79.36M | +192.0% | +107.0% |
| June 30, 2025 | $38.33M | +146.2% | +7.3% |
| March 31, 2025 | $35.73M | +3734.0% | +31.5% |
| September 30, 2024 | $27.18M | -66.3% | +74.6% |
| June 30, 2024 | $15.57M | +146.9% | +1570.4% |
| March 31, 2024 | $932.0K | +102.1% | -98.8% |
| September 30, 2023 | $80.75M | +370.5% | +343.1% |
| June 30, 2023 | -$33.21M | -18.2% | +26.7% |
- Krystal Biotech, Inc. showed an increase of +129.7% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, Krystal Biotech, Inc.’s net income has grown by 17911.4% (from -$1.15 million to $204.83 million).
- The most recent figure is from Krystal Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: